{"entity":{"type":"insider","cik":"0001344740","url":"/insider/0001344740","json_url":"/insider/0001344740.json","name":"Aberman Zami","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":28,"n_filings":20,"first":"2006-01-18","last":"2022-12-22","span_basis":"filed_date"},"name_variants":[{"name":"Aberman Zami","source":"filing","n_filings":20,"first_seen":"2006-01-18","last_seen":"2022-12-22"}],"transactions":[{"id":6615671,"accession":"0001213900-22-081968","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-22-081968","line_url":"/filing/0001213900-22-081968#line-1","is_derivative":false,"issuer_cik":"0001158780","issuer_name":"Pluri Inc.","issuer_ticker":"PLUR","issuer_name_source":null,"issuer_url":"/issuer/0001158780","owner_cik":"0001344740","owner_name":"Aberman Zami","owner_display_name":"Aberman Zami","owner_url":"/insider/0001344740","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":0.97,"price_display":"0.97","price_state":"stated","total_value":1940.0,"total_display":"1,940.00","total_whole":"1,940","shares_owned_after":1491973.0,"shares_owned_after_display":"1,491,973","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-20","filed_date":"2022-12-22","scope":"insider"},{"id":6958153,"accession":"0001213900-22-007471","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-22-007471","line_url":"/filing/0001213900-22-007471#line-1","is_derivative":false,"issuer_cik":"0001158780","issuer_name":"PLURISTEM THERAPEUTICS INC","issuer_ticker":"PSTI","issuer_name_source":null,"issuer_url":"/issuer/0001158780","owner_cik":"0001344740","owner_name":"Aberman Zami","owner_display_name":"Aberman Zami","owner_url":"/insider/0001344740","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":80616.0,"shares_display":"80,616","price_per_share":1.8,"price_display":"1.80","price_state":"stated","total_value":145108.8,"total_display":"145,108.80","total_whole":"145,109","shares_owned_after":91756.0,"shares_owned_after_display":"91,756","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-02-10","filed_date":"2022-02-14","scope":"insider"},{"id":8038704,"accession":"0001178913-19-001086","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001178913-19-001086","line_url":"/filing/0001178913-19-001086#line-1","is_derivative":false,"issuer_cik":"0001158780","issuer_name":"PLURISTEM THERAPEUTICS INC","issuer_ticker":"PSTI","issuer_name_source":null,"issuer_url":"/issuer/0001158780","owner_cik":"0001344740","owner_name":"Aberman Zami","owner_display_name":"Aberman Zami","owner_url":"/insider/0001344740","role":"Director, Officer (Co-CEO & Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Co-CEO & Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":71429.0,"shares_display":"71,429","price_per_share":0.7,"price_display":"0.70","price_state":"stated","total_value":50000.3,"total_display":"50,000.30","total_whole":"50,000","shares_owned_after":4939727.0,"shares_owned_after_display":"4,939,727","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-04-08","filed_date":"2019-04-08","scope":"insider"},{"id":2041138,"accession":"0001178913-16-004512","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001178913-16-004512","line_url":"/filing/0001178913-16-004512#line-1","is_derivative":false,"issuer_cik":"0001158780","issuer_name":"PLURISTEM THERAPEUTICS INC","issuer_ticker":"PSTI","issuer_name_source":null,"issuer_url":"/issuer/0001158780","owner_cik":"0001344740","owner_name":"Aberman Zami","owner_display_name":"Aberman Zami","owner_url":"/insider/0001344740","role":"Director, Officer (CEO & Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.33,"price_display":"1.33","price_state":"stated","total_value":6650.0,"total_display":"6,650.00","total_whole":"6,650","shares_owned_after":111400.0,"shares_owned_after_display":"111,400","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-02-22","filed_date":"2016-02-24","scope":"insider"},{"id":3251000,"accession":"0001178913-16-004435","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001178913-16-004435","line_url":"/filing/0001178913-16-004435","is_derivative":false,"issuer_cik":"0001158780","issuer_name":"PLURISTEM THERAPEUTICS INC","issuer_ticker":"PSTI","issuer_name_source":null,"issuer_url":"/issuer/0001158780","owner_cik":"0001344740","owner_name":"Aberman Zami","owner_display_name":"Aberman Zami","owner_url":"/insider/0001344740","role":"Director, Officer (CEO & Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":1.066,"price_display":"1.07","price_state":"stated","total_value":15990.0,"total_display":"15,990.00","total_whole":"15,990","shares_owned_after":100400.0,"shares_owned_after_display":"100,400","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-02-16","filed_date":"2016-02-17","scope":"insider","n_lines":2},{"id":2156536,"accession":"0001178913-16-004401","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001178913-16-004401","line_url":"/filing/0001178913-16-004401#line-1","is_derivative":false,"issuer_cik":"0001158780","issuer_name":"PLURISTEM THERAPEUTICS INC","issuer_ticker":"PSTI","issuer_name_source":null,"issuer_url":"/issuer/0001158780","owner_cik":"0001344740","owner_name":"Aberman Zami","owner_display_name":"Aberman Zami","owner_url":"/insider/0001344740","role":"Director, Officer (CEO & Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":31000.0,"shares_display":"31,000","price_per_share":0.7973,"price_display":"0.80","price_state":"stated","total_value":24716.3,"total_display":"24,716.30","total_whole":"24,716","shares_owned_after":91400.0,"shares_owned_after_display":"91,400","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-02-11","filed_date":"2016-02-16","scope":"insider"},{"id":8683984,"accession":"0001178913-15-003467","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001178913-15-003467","line_url":"/filing/0001178913-15-003467#line-1","is_derivative":false,"issuer_cik":"0001158780","issuer_name":"PLURISTEM THERAPEUTICS INC","issuer_ticker":"PSTI","issuer_name_source":null,"issuer_url":"/issuer/0001158780","owner_cik":"0001344740","owner_name":"Aberman Zami","owner_display_name":"Aberman Zami","owner_url":"/insider/0001344740","role":"Director, Officer (CEO & Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9900.0,"shares_display":"9,900","price_per_share":1.49,"price_display":"1.49","price_state":"stated","total_value":14751.0,"total_display":"14,751.00","total_whole":"14,751","shares_owned_after":60400.0,"shares_owned_after_display":"60,400","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-11-16","filed_date":"2015-11-17","scope":"insider"},{"id":8800846,"accession":"0001178913-15-002918","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001178913-15-002918","line_url":"/filing/0001178913-15-002918","is_derivative":false,"issuer_cik":"0001158780","issuer_name":"PLURISTEM THERAPEUTICS INC","issuer_ticker":"PSTI","issuer_name_source":null,"issuer_url":"/issuer/0001158780","owner_cik":"0001344740","owner_name":"Aberman Zami","owner_display_name":"Aberman Zami","owner_url":"/insider/0001344740","role":"Director, Officer (CEO & Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25500.0,"shares_display":"25,500","price_per_share":2.109019607843137,"price_display":"2.11","price_state":"stated","total_value":53780.0,"total_display":"53,780.00","total_whole":"53,780","shares_owned_after":50500.0,"shares_owned_after_display":"50,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-09-21","filed_date":"2015-09-21","scope":"insider","n_lines":2},{"id":8877508,"accession":"0001178913-15-002863","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001178913-15-002863","line_url":"/filing/0001178913-15-002863","is_derivative":false,"issuer_cik":"0001158780","issuer_name":"PLURISTEM THERAPEUTICS INC","issuer_ticker":"PSTI","issuer_name_source":null,"issuer_url":"/issuer/0001158780","owner_cik":"0001344740","owner_name":"Aberman Zami","owner_display_name":"Aberman Zami","owner_url":"/insider/0001344740","role":"Director, Officer (CEO & Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":2.11,"price_display":"2.11","price_state":"stated","total_value":52750.0,"total_display":"52,750.00","total_whole":"52,750","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-09-15","filed_date":"2015-09-16","scope":"insider","n_lines":3},{"id":6607196,"accession":"0001178913-14-003463","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001178913-14-003463","line_url":"/filing/0001178913-14-003463","is_derivative":false,"issuer_cik":"0001158780","issuer_name":"PLURISTEM THERAPEUTICS INC","issuer_ticker":"PSTI","issuer_name_source":null,"issuer_url":"/issuer/0001158780","owner_cik":"0001344740","owner_name":"Aberman Zami","owner_display_name":"Aberman Zami","owner_url":"/insider/0001344740","role":"Director, Officer (CEO & Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13000.0,"shares_display":"13,000","price_per_share":2.635,"price_display":"2.64","price_state":"stated","total_value":34255.0,"total_display":"34,255.00","total_whole":"34,255","shares_owned_after":1768298.0,"shares_owned_after_display":"1,768,298","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-11","filed_date":"2014-11-12","scope":"insider","n_lines":2},{"id":6174308,"accession":"0001178913-14-003018","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001178913-14-003018","line_url":"/filing/0001178913-14-003018#line-1","is_derivative":false,"issuer_cik":"0001158780","issuer_name":"PLURISTEM THERAPEUTICS INC","issuer_ticker":"PSTI","issuer_name_source":null,"issuer_url":"/issuer/0001158780","owner_cik":"0001344740","owner_name":"Aberman Zami","owner_display_name":"Aberman Zami","owner_url":"/insider/0001344740","role":"Director, Officer (CEO & Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":2.92,"price_display":"2.92","price_state":"stated","total_value":14600.0,"total_display":"14,600.00","total_whole":"14,600","shares_owned_after":1755298.0,"shares_owned_after_display":"1,755,298","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-22","filed_date":"2014-09-23","scope":"insider"},{"id":6958590,"accession":"0001178913-14-002992","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001178913-14-002992","line_url":"/filing/0001178913-14-002992","is_derivative":false,"issuer_cik":"0001158780","issuer_name":"PLURISTEM THERAPEUTICS INC","issuer_ticker":"PSTI","issuer_name_source":null,"issuer_url":"/issuer/0001158780","owner_cik":"0001344740","owner_name":"Aberman Zami","owner_display_name":"Aberman Zami","owner_url":"/insider/0001344740","role":"Director, Officer (CEO & Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":2.955,"price_display":"2.96","price_state":"stated","total_value":14775.0,"total_display":"14,775.00","total_whole":"14,775","shares_owned_after":1750298.0,"shares_owned_after_display":"1,750,298","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-21","filed_date":"2014-09-22","scope":"insider","n_lines":2},{"id":6903060,"accession":"0001178913-14-002948","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001178913-14-002948","line_url":"/filing/0001178913-14-002948#line-1","is_derivative":false,"issuer_cik":"0001158780","issuer_name":"PLURISTEM THERAPEUTICS INC","issuer_ticker":"PSTI","issuer_name_source":null,"issuer_url":"/issuer/0001158780","owner_cik":"0001344740","owner_name":"Aberman Zami","owner_display_name":"Aberman Zami","owner_url":"/insider/0001344740","role":"Director, Officer (CEO & Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":2.8,"price_display":"2.80","price_state":"stated","total_value":42000.0,"total_display":"42,000.00","total_whole":"42,000","shares_owned_after":1730298.0,"shares_owned_after_display":"1,730,298","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-16","filed_date":"2014-09-16","scope":"insider"},{"id":6547004,"accession":"0001178913-14-002964","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001178913-14-002964","line_url":"/filing/0001178913-14-002964#line-1","is_derivative":false,"issuer_cik":"0001158780","issuer_name":"PLURISTEM THERAPEUTICS INC","issuer_ticker":"PSTI","issuer_name_source":null,"issuer_url":"/issuer/0001158780","owner_cik":"0001344740","owner_name":"Aberman Zami","owner_display_name":"Aberman Zami","owner_url":"/insider/0001344740","role":"Director, Officer (CEO & Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":2.84,"price_display":"2.84","price_state":"stated","total_value":42600.0,"total_display":"42,600.00","total_whole":"42,600","shares_owned_after":1745298.0,"shares_owned_after_display":"1,745,298","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-16","filed_date":"2014-09-17","scope":"insider"},{"id":6302806,"accession":"0001178913-14-000157","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001178913-14-000157","line_url":"/filing/0001178913-14-000157#line-2","is_derivative":false,"issuer_cik":"0001158780","issuer_name":"PLURISTEM THERAPEUTICS INC","issuer_ticker":"PSTI","issuer_name_source":null,"issuer_url":"/issuer/0001158780","owner_cik":"0001344740","owner_name":"Aberman Zami","owner_display_name":"Aberman Zami","owner_url":"/insider/0001344740","role":"Director, Officer (CEO & Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":67850.0,"shares_display":"67,850","price_per_share":4.296,"price_display":"4.30","price_state":"stated","total_value":291483.6,"total_display":"291,483.60","total_whole":"291,484","shares_owned_after":1715298.0,"shares_owned_after_display":"1,715,298","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-13","filed_date":"2014-01-14","scope":"insider"},{"id":6302800,"accession":"0001178913-14-000157","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001178913-14-000157","line_url":"/filing/0001178913-14-000157#line-1","is_derivative":false,"issuer_cik":"0001158780","issuer_name":"PLURISTEM THERAPEUTICS INC","issuer_ticker":"PSTI","issuer_name_source":null,"issuer_url":"/issuer/0001158780","owner_cik":"0001344740","owner_name":"Aberman Zami","owner_display_name":"Aberman Zami","owner_url":"/insider/0001344740","role":"Director, Officer (CEO & Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":4.25,"price_display":"4.25","price_state":"stated","total_value":8500.0,"total_display":"8,500.00","total_whole":"8,500","shares_owned_after":1783148.0,"shares_owned_after_display":"1,783,148","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-10","filed_date":"2014-01-14","scope":"insider"},{"id":6212408,"accession":"0001178913-14-000090","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001178913-14-000090","line_url":"/filing/0001178913-14-000090#line-2","is_derivative":false,"issuer_cik":"0001158780","issuer_name":"PLURISTEM THERAPEUTICS INC","issuer_ticker":"PSTI","issuer_name_source":null,"issuer_url":"/issuer/0001158780","owner_cik":"0001344740","owner_name":"Aberman Zami","owner_display_name":"Aberman Zami","owner_url":"/insider/0001344740","role":"Director, Officer (CEO & Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150.0,"shares_display":"150","price_per_share":4.25,"price_display":"4.25","price_state":"stated","total_value":637.5,"total_display":"637.50","total_whole":"638","shares_owned_after":1785148.0,"shares_owned_after_display":"1,785,148","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-09","filed_date":"2014-01-09","scope":"insider"},{"id":6212405,"accession":"0001178913-14-000090","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001178913-14-000090","line_url":"/filing/0001178913-14-000090#line-1","is_derivative":false,"issuer_cik":"0001158780","issuer_name":"PLURISTEM THERAPEUTICS INC","issuer_ticker":"PSTI","issuer_name_source":null,"issuer_url":"/issuer/0001158780","owner_cik":"0001344740","owner_name":"Aberman Zami","owner_display_name":"Aberman Zami","owner_url":"/insider/0001344740","role":"Director, Officer (CEO & Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":4.25,"price_display":"4.25","price_state":"stated","total_value":127500.0,"total_display":"127,500.00","total_whole":"127,500","shares_owned_after":1785298.0,"shares_owned_after_display":"1,785,298","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-08","filed_date":"2014-01-09","scope":"insider"},{"id":3537477,"accession":"0001178913-12-002388","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001178913-12-002388","line_url":"/filing/0001178913-12-002388#line-1","is_derivative":false,"issuer_cik":"0001158780","issuer_name":"PLURISTEM THERAPEUTICS INC","issuer_ticker":"PSTI","issuer_name_source":null,"issuer_url":"/issuer/0001158780","owner_cik":"0001344740","owner_name":"Aberman Zami","owner_display_name":"Aberman Zami","owner_url":"/insider/0001344740","role":"Director, Officer (CEO & Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33853.0,"shares_display":"33,853","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":169265.0,"total_display":"169,265.00","total_whole":"169,265","shares_owned_after":1315298.0,"shares_owned_after_display":"1,315,298","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-08-17","filed_date":"2012-08-21","scope":"insider"},{"id":8922648,"accession":"0001178913-11-000176","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001178913-11-000176","line_url":"/filing/0001178913-11-000176#line-1","is_derivative":false,"issuer_cik":"0001158780","issuer_name":"PLURISTEM THERAPEUTICS INC","issuer_ticker":"PSTI","issuer_name_source":null,"issuer_url":"/issuer/0001158780","owner_cik":"0001344740","owner_name":"Aberman Zami","owner_display_name":"Aberman Zami","owner_url":"/insider/0001344740","role":"Director, Officer (CEO & Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":3.2,"price_display":"3.20","price_state":"stated","total_value":80000.0,"total_display":"80,000.00","total_whole":"80,000","shares_owned_after":849151.0,"shares_owned_after_display":"849,151","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-01-18","filed_date":"2011-01-20","scope":"insider"},{"id":8974838,"accession":"0001178913-11-000120","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001178913-11-000120","line_url":"/filing/0001178913-11-000120#line-1","is_derivative":false,"issuer_cik":"0001158780","issuer_name":"PLURISTEM THERAPEUTICS INC","issuer_ticker":"PSTI","issuer_name_source":null,"issuer_url":"/issuer/0001158780","owner_cik":"0001344740","owner_name":"Aberman Zami","owner_display_name":"Aberman Zami","owner_url":"/insider/0001344740","role":"Director, Officer (CEO & Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":2.6,"price_display":"2.60","price_state":"stated","total_value":65000.0,"total_display":"65,000.00","total_whole":"65,000","shares_owned_after":874151.0,"shares_owned_after_display":"874,151","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-01-11","filed_date":"2011-01-13","scope":"insider"},{"id":4076774,"accession":"0001085037-06-000080","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001085037-06-000080","line_url":"/filing/0001085037-06-000080#line-1","is_derivative":false,"issuer_cik":"0001158780","issuer_name":"PLURISTEM LIFE SYSTEMS INC","issuer_ticker":"PLRS","issuer_name_source":null,"issuer_url":"/issuer/0001158780","owner_cik":"0001344740","owner_name":"Aberman Zami","owner_display_name":"Aberman Zami","owner_url":"/insider/0001344740","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"common shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":0.099,"price_display":"0.10","price_state":"stated","total_value":297.0,"total_display":"297.00","total_whole":"297","shares_owned_after":3000.0,"shares_owned_after_display":"3,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-01-11","filed_date":"2006-01-18","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":28,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":20,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":28},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001158780","name":"Pluri Inc.","url":"/issuer/0001158780","role":"Director, Officer (Co-CEO & Chairman)","n_filings":20,"first_seen":"2006-01-18","last_seen":"2022-12-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001344740","retrieved_at":"2026-08-26T14:49:36+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}